Labcorp Overhauls Clinical Trial Platform to Streamline Complex Studies
Event summary
- Labcorp launched an enhanced version of its Labcorp Global Trial Connect™ platform on August 31, 2026.
- The redesign includes a unified Study Oversight Dashboard and a Report Wizard for simplified reporting.
- Key updates were informed by feedback from over 80 sponsors and 100 investigator sites worldwide.
- The platform aims to reduce manual data entry by 75% through embedded in-portal kit ordering.
- Labcorp's Biopharma Laboratory Services business continues to invest in digital solutions for clinical trials.
The big picture
Labcorp's platform upgrade reflects the growing demand for digital solutions in clinical trials, as sponsors seek to manage increasing complexity. The enhancements align with broader industry trends toward data-driven trial management and operational efficiency. With nearly 71,000 employees and support for 85% of FDA-approved new drugs in 2025, Labcorp's move underscores its position as a key player in the biopharma services market.
What we're watching
- Adoption Pace
- How quickly sponsors and investigator sites will integrate the enhanced platform into their workflows.
- Competitive Response
- Whether rivals like IQVIA or PPD will accelerate their own digital platform upgrades.
- Operational Impact
- The extent to which the platform improvements reduce trial timelines and costs for biopharma clients.
Related topics